Timing note: Today is Friday, July 31, 2026. LIN’s 2Q26 earnings call is scheduled for today, not tomorrow. This preview therefore uses information available through the July 30 close.
Linde enters 2Q with a familiar setup: a high-quality, defensively positioned industrial-gas franchise that has already guided to solid earnings growth, but with investor attention focused less on the reported EPS result and more on the quality and durability of the exit rate.
Management’s 2Q outlook is adjusted EPS of $4.40–$4.50, representing 8–10% year-over-year growth versus $4.09 in 2Q25. The midpoint is $4.45. For FY26, Linde guides to $17.60–$17.90, or 7–9% growth, including an assumed ~1% currency tailwind. The report needs to demonstrate that organic growth, pricing/productivity, backlog execution, and capital allocation can sustain the company’s longer-term compounding algorithm even while Europe remains soft.
LIN closed July 30 at $508.68, up about 19.3% year-to-date, but roughly 6.9% below its July 2 closing high of $546.64. The pullback raises the importance of a constructive outlook—particularly a full-year guide increase, evidence of incremental helium upside, or further electronics-project awards.
The headline hurdle is clear:
| Metric | 2Q25 actual | 2Q26 company outlook | Midpoint |
|---|---|---|---|
| Adjusted EPS | $4.09 | $4.40–$4.50 | $4.45 |
| YoY growth | — | 8–10% | ~9% |
At the midpoint, the guide implies approximately 8.8% year-over-year EPS growth.
Linde raised the bottom end of its FY26 adjusted-EPS range by $0.20 after 1Q, but retained the $17.90 high end because management wanted more clarity on macro and geopolitical conditions. A clean result near or above the high end of 2Q guidance, combined with stable-to-improving regional trends, would increase the case for an upward revision to the annual range.
Investor read-through: - Bullish: 2Q EPS above $4.50, a higher FY26 range, or a clear top-end bias tied to helium, Americas volumes, FX, or productivity. - Adequate: EPS in-range and FY guide reiterated, with continued margin expansion. - Disappointing: An in-range quarter accompanied by a more cautious macro outlook, lower confidence in EMEA, or evidence that helium/project timing upside is slipping.
The Americas were the standout in 1Q: underlying sales rose 6%, comprising 4% price and 2% volume, while operating margin reached 31.6%, up 60 basis points year over year.
Management cited several favorable vectors that should be tested in 2Q:
The crucial question is whether these conditions are producing base-volume growth, rather than merely project-startup growth. In 1Q, global reported volume growth was 1%, largely related to projects, though management said base volumes had turned modestly positive.
Helium may be the most important incremental earnings variable. Management indicated that the FY26 and 2Q outlooks did not assume improvement in helium, despite global supply disruptions and improving pricing conditions.
Linde’s priorities are to: 1. Fulfill existing contractual commitments; 2. Use excess molecules to secure attractive new multiyear contracts; and 3. Capture price improvements as contracts reset.
The company said its helium business is roughly 85–90% contracted, which limits near-term spot-market exposure but provides a route for longer-duration price and volume upside. Investors will look for specifics on: - Recent contract wins and duration; - The scale of excess supply available after serving existing customers; - Price-reset cadence; - Whether the supply disruption is likely to persist long enough to alter FY26 earnings meaningfully.
A material helium contribution would be particularly constructive because it is not required to achieve current guidance.
Electronics grew 10% in 1Q, supported by advanced-chip investment in the U.S., China, and Korea. Linde is investing more than $1 billion of its project backlog in ultra-high-purity plants for advanced semiconductor fabs.
At the 1Q call, management expressed high confidence in additional electronics awards during 2026 and suggested sale-of-gas backlog could potentially rise from $7.1 billion to an “8-handle” by year-end. New awards would not necessarily move 2026 EPS materially, but they would reinforce visibility into future growth and capital deployment.
Key items to watch: - Announced electronics project wins; - Change in the $7.1 billion sale-of-gas backlog; - Project startups and capex conversion; - Commentary on customer spending discipline, especially in AI-led semiconductor capacity additions.
EMEA remains the weak point. In 1Q, underlying sales declined 2%, with 1% price offset by a 3% volume decline. Management attributed the pressure to weak industrial activity, chemical-industry softness, and customers shifting production toward more feedstock-advantaged regions.
A weak EMEA environment does not necessarily impair Linde’s earnings resilience—its contracts, pricing discipline, and cost actions protect margins better than those of many industrial peers—but it limits the probability of a broad global volume recovery.
For 2Q, investors should watch: - Whether European industrial-gas volumes stabilize sequentially; - EMEA margin progression after a 1Q decline; - Energy-price volatility and whether surcharges begin to convert to structural pricing; - Whether investment-policy or trade-policy catalysts are improving customer activity.
Linde delivered a 30.0% adjusted operating margin in 1Q, essentially flat year over year but up sequentially. Management stated it expects FY26 margin expansion at the upper end of—or potentially above—its typical 40–60 basis point range.
That makes segment mix and productivity especially important: - Americas: Margin strength should remain a tailwind. - APAC: 1Q margin was pressured by seasonal effects and lower-margin equipment sales tied to electronics projects; management expects a return toward approximately 29% margins. - EMEA: Volumes remain the primary obstacle to margin improvement.
Cash flow merits attention because Linde is investing heavily while preserving shareholder returns. FY26 capital expenditures are expected to be $5.0–$5.5 billion, funding maintenance, growth investments, and backlog execution. In 1Q, Linde generated $2.2 billion of operating cash flow and $898 million of free cash flow after $1.34 billion of capex, while returning $1.55 billion through dividends and net buybacks.
A constructive report would show that elevated project investment is translating into backlog starts, attractive returns, and continued capacity for dividends and repurchases.
Management previously said the Woodside project’s nitrogen component was expected to start during 2026, while the larger hydrogen/ATR and sequestration components had slipped into 1Q27 because of a difficult U.S. Gulf Coast construction and subcontractor environment.
This should be treated primarily as a timing issue, rather than a strategic concern. Still, investors should listen for: - Confirmation of the 2Q nitrogen startup; - Any additional slippage on the larger 1Q27 components; - The expected earnings/cash-flow contribution profile as the facility ramps.
Linde does not need a dramatic macro recovery to produce a good quarter. Its current guidance explicitly assumes no economic improvement at the midpoint, while helium upside is excluded. The more favorable 2Q setup rests on solid Americas activity, disciplined pricing and productivity, electronics investment, project execution, and potential helium benefits.
The strongest outcome would be an above-range EPS result paired with a higher FY26 guide, improved confidence in Americas base volumes, confirmation of electronics backlog growth, and quantifiable helium upside. The main risk is that persistent EMEA weakness, project timing, or a cautious global-demand outlook prevents management from moving beyond a “meet-and-maintain” guidance posture.
Not investment advice.